Cross Cancer Centre

Edmonton, Alberta T6G1Z2

0 studies enrolling now · 3 studies all time

What they study most

Epithelial Ovarian Cancer, Fallopian Tube Cancer, Lymphoma, T-Cell, Cutaneous, Mycosis Fungoides, Ovarian Cancer, Peritoneal Cancer, Sezary Syndrome

Studies at this site

• A Study of Rucaparib in Patients With Platinum-Sensitive, Relapsed, High-Grade Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (ARIEL2) — Completed
• Study of ONTAK (Denileukin Diftitox) in Cutaneous T-Cell Lymphoma (CTCL) Patients — Completed
• Study of ONTAK (Denileukin Diftitox) in Previously Treated Cutaneous T-Cell Lymphoma Patients — Completed